The ROCA Test
The ROCA Test is a simple blood test that assesses a woman’s risk of having ovarian cancer. It is intended for women who are between 35 and 85 years old who have tested positive for BRCA1 or BRCA2 gene mutation and who wish to delay risk reducing surgery. The ROCA Test has been evaluated in several prospective clinical trials, including the UK Familial Ovarian Cancer Screening Study (UKFOCSS) and a NHS partnered real world study (ALDO).
To learn more about the ROCA Test, please go to our product site or view the product publications.